Stock Code: 000999 stock abbreviation: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) No.: 2022-007
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Important:
1. There is no resolution at this shareholders’ meeting.
2. This shareholders’ meeting does not involve changing the resolutions adopted at the previous shareholders’ meeting.
1、 Convening and attendance of the meeting
1. China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) the first extraordinary general meeting of shareholders in 2022 will be held by combining on-site voting and online voting. The on-site meeting was held at 14:30 p.m. on January 20, 2022 in conference room 107 of the company’s comprehensive office center. Meanwhile, the voting time for the shareholders’ meeting to pass the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on January 20, 2022; The time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 to 15:00 on January 20, 2022.
2. The shareholders attending the general meeting are as follows:
Number of shareholders attending the meeting and authorized representatives of shareholders 14
Number of representative shares (shares) 698061058
Proportion in total voting shares of the company (%) 71.3108
among
1. Number of shareholders attending the on-site meeting and authorized representatives of shareholders 7
Number of representative shares (shares) 634168082
Proportion in total voting shares of the company (%) 64.7837
2. Number of shareholders participating in online voting and authorized representatives of shareholders 7
Number of representative shares (shares) 63892976
Proportion in total voting shares of the company (%) 6.5270
3. Minority shareholders participating in voting (except directors, supervisors and senior managers of the company)
And shares other than shareholders who individually or jointly hold more than 5% of the shares of the company 13
(East) and number of authorized representatives of shareholders
Number of representative shares (shares) 75491426
Proportion in total voting shares of the company (%) 7.7119
3. The general meeting of shareholders was convened by the board of directors of the company and presided over by Ms. Zhou Hui. Some directors, supervisors, senior managers and witness lawyers of the company attended the meeting.
4. The convening of this shareholders’ meeting complies with the provisions of the company law, the rules for the shareholders’ meeting of listed companies, the stock listing rules of Shenzhen Stock Exchange, the articles of association and other laws, regulations and normative documents.
2、 Consideration and voting of proposals
1. Voting method: on-site written voting and online voting
2. Voting results
(1) Proposal on the estimated amount of daily connected transactions in 2022
This proposal is a related party transaction proposal. The related shareholder China Resources Pharmaceutical Holdings Co., Ltd. holds 622569632 shares of the company and avoids voting on this proposal.
Overall voting: 62295262 shares were approved, accounting for 82.5197% of the total number of valid voting shares attending the general meeting of shareholders; 12795527 opposed shares, accounting for 16.9496% of the total number of valid voting shares attending the general meeting of shareholders; 400637 shares were abstained, accounting for 0.5307% of the total number of valid voting shares attending the general meeting of shareholders.
Among them, the voting of minority shareholders (other than directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the company’s shares): 62295262 shares were agreed, accounting for 82.5197% of the shares held by minority shareholders attending the meeting; Against 12795527 shares, accounting for 16.9496% of the shares held by minority shareholders attending the meeting; 400637 shares were abstained, accounting for 0.5307% of the shares held by minority shareholders attending the meeting.
Voting result: adopted
(2) Proposal on purchasing directors, supervisors and senior managers’ liability insurance
Overall voting: 694473315 shares were approved, accounting for 99.4860% of the total number of valid voting shares attending the general meeting of shareholders; 3096594 opposed shares, accounting for 0.4436% of the total number of valid voting shares attending the general meeting of shareholders; 491149 shares were abstained, accounting for 0.0704% of the total number of valid voting shares attending the general meeting of shareholders.
Among them, the voting of minority shareholders (other than directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the company’s shares): 71903683 shares were agreed, accounting for 95.2475% of the shares held by minority shareholders attending the meeting; 3096594 shares were opposed, accounting for 4.1019% of the shares held by minority shareholders attending the meeting; 491149 shares were abstained, accounting for 0.6506% of the shares held by minority shareholders attending the meeting.
Voting result: adopted
3、 Legal opinions issued by lawyers
Lawyer Mai Shuzhi and lawyer Li Fang of Shanghai jintiancheng (Shenzhen) law firm attended the shareholders’ meeting and issued a legal opinion. They believed that the convening and convening procedures, the qualifications of attendees, the qualifications of conveners, the voting procedures and voting results of the meeting were in line with the company law, the rules for the shareholders’ meeting of listed companies and other laws The relevant provisions of laws, regulations, other normative documents and the articles of association are legal and valid. 4、 Directory of documents for future reference
1. China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) resolution of the first extraordinary general meeting of shareholders in 2022
2. Legal opinion issued by lawyer
It is hereby announced.
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) board of directors
January 20, 2002
